Starting at $175/month Targets GLP-1 receptors only Average 1517% body weight loss (STEP trial data) Once-weekly subcutaneous injection Strong evidence for cardiovascular benefit Often the right starting medication Compounded by licensed 503A pharmacy Patients new to GLP-1 therapy, those with cardiovascular risk factors, or anyone seeking a well-studied first-line option with proven, sustainable results
Results that last
Each 40mg Retatrutide Research Kit Includes: 1 Pre-filled research pen (40mg total Retatrutide) Detailed research information sheet Storage Instructions: Keep refrigerated at 28C
As the program launches in 2026, it could become a helpful option for individuals managing obesity and related conditions
Weve also explored how adding Vitamin C can act as a force multiplier for both supplements, and how a consistent morning routine can make these habits stick
If a patient is coming to the end of GLP-1 treatment, reducing medication or asking how to maintain weight loss after stopping, this book gives them a practical framework for the next phase
